{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T05:33:18Z","timestamp":1791005598986,"version":"4.1.0"},"reference-count":95,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,7,4]],"date-time":"2025-07-04T00:00:00Z","timestamp":1751587200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["IgG1 b12"],"award-info":[{"award-number":["IgG1 b12"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["UM1AI164562"],"award-info":[{"award-number":["UM1AI164562"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01AI150322"],"award-info":[{"award-number":["R01AI150322"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01AI186809"],"award-info":[{"award-number":["R01AI186809"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01AI176531"],"award-info":[{"award-number":["R01AI176531"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01AI148379"],"award-info":[{"award-number":["R01AI148379"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["P01AI162242"],"award-info":[{"award-number":["P01AI162242"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01AI174908"],"award-info":[{"award-number":["R01AI174908"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["ZIA BC 011466"],"award-info":[{"award-number":["ZIA BC 011466"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["FBD-193357"],"award-info":[{"award-number":["FBD-193357"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000024","name":"Canadian Institutes of Health Research","doi-asserted-by":"publisher","award":["41027"],"award-info":[{"award-number":["41027"]}],"id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000024","name":"Canadian Institutes of Health Research","doi-asserted-by":"publisher","award":["R01AI176531"],"award-info":[{"award-number":["R01AI176531"]}],"id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000024","name":"Canadian Institutes of Health Research","doi-asserted-by":"publisher","award":["R01AI174908"],"award-info":[{"award-number":["R01AI174908"]}],"id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000024","name":"Canadian Institutes of Health Research","doi-asserted-by":"publisher","award":["P01AI162242"],"award-info":[{"award-number":["P01AI162242"]}],"id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000024","name":"Canadian Institutes of Health Research","doi-asserted-by":"publisher","award":["UM1AI164562"],"award-info":[{"award-number":["UM1AI164562"]}],"id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000024","name":"Canadian Institutes of Health Research","doi-asserted-by":"publisher","award":["R01AI186809"],"award-info":[{"award-number":["R01AI186809"]}],"id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000024","name":"Canadian Institutes of Health Research","doi-asserted-by":"publisher","award":["R01AI150322"],"award-info":[{"award-number":["R01AI150322"]}],"id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000024","name":"Canadian Institutes of Health Research","doi-asserted-by":"publisher","award":["R01AI148379"],"award-info":[{"award-number":["R01AI148379"]}],"id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100022991","name":"HIV\/AIDS and STBBI Research Initiative","doi-asserted-by":"publisher","award":["HAL-157985"],"award-info":[{"award-number":["HAL-157985"]}],"id":[{"id":"10.13039\/100022991","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100022991","name":"HIV\/AIDS and STBBI Research Initiative","doi-asserted-by":"publisher","award":["197728"],"award-info":[{"award-number":["197728"]}],"id":[{"id":"10.13039\/100022991","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000156","name":"Sant\u00e9","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000156","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000196","name":"Canada Foundation for Innovation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000196","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["eBioMedicine"],"published-print":{"date-parts":[[2025,8]]},"DOI":"10.1016\/j.ebiom.2025.105856","type":"journal-article","created":{"date-parts":[[2025,7,19]],"date-time":"2025-07-19T12:00:48Z","timestamp":1752926448000},"page":"105856","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"special_numbering":"C","title":["CD4 T cell counts are inversely correlated with anti-gp120 cluster A antibodies in antiretroviral therapy-treated PLWH"],"prefix":"10.1016","volume":"118","author":[{"given":"Mehdi","family":"Benlarbi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan","family":"Richard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tommaso","family":"Clemente","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catherine","family":"Bourassa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William D.","family":"Tolbert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suneetha","family":"Gottumukkala","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marc","family":"Messier-Peet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Halima","family":"Medjahed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marzena","family":"Pazgier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frank","family":"Maldarelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonella","family":"Castagna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Madeleine","family":"Durand","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andr\u00e9s","family":"Finzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.ebiom.2025.105856_bib1","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1084\/jem.20040874","article-title":"CD4+ T cell depletion during all stages of HIV disease occurs predominantly in the gastrointestinal tract","volume":"200","author":"Brenchley","year":"2004","journal-title":"J Exp Med"},{"issue":"3","key":"10.1016\/j.ebiom.2025.105856_bib2","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1016\/j.chom.2016.02.012","article-title":"Dissecting how CD4 T cells are lost during HIV infection","volume":"19","author":"Doitsh","year":"2016","journal-title":"Cell Host Microbe"},{"issue":"6831","key":"10.1016\/j.ebiom.2025.105856_bib3","doi-asserted-by":"crossref","first-page":"974","DOI":"10.1038\/35073648","article-title":"The dynamics of CD4+ T-cell depletion in HIV disease","volume":"410","author":"McCune","year":"2001","journal-title":"Nature"},{"issue":"11","key":"10.1016\/j.ebiom.2025.105856_bib4","doi-asserted-by":"crossref","first-page":"3725","DOI":"10.4049\/jimmunol.138.11.3725","article-title":"Early effects of HIV on CD4 lymphocytes in vivo","volume":"138","author":"Giorgi","year":"1987","journal-title":"J Immunol"},{"issue":"10","key":"10.1016\/j.ebiom.2025.105856_bib5","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1038\/s41579-023-00914-1","article-title":"Prevention, treatment and cure of HIV infection","volume":"21","author":"Landovitz","year":"2023","journal-title":"Nat Rev Microbiol"},{"issue":"1","key":"10.1016\/j.ebiom.2025.105856_bib6","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1001\/jama.2022.22246","article-title":"Antiretroviral drugs for treatment and prevention of HIV infection in adults: 2022 recommendations of the International Antiviral Society-USA panel","volume":"329","author":"Gandhi","year":"2023","journal-title":"JAMA"},{"issue":"9","key":"10.1016\/j.ebiom.2025.105856_bib7","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1056\/NEJMoa1600693","article-title":"Antiretroviral therapy for the prevention of HIV-1 transmission","volume":"375","author":"Cohen","year":"2016","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ebiom.2025.105856_bib8","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2024.1487565","article-title":"Editorial: immunological non-responders in HIV infection","volume":"15","author":"Saidakova","year":"2024","journal-title":"Front Immunol"},{"issue":"4","key":"10.1016\/j.ebiom.2025.105856_bib9","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1002\/JLB.4MR1019-189R","article-title":"Incomplete immune reconstitution in HIV\/AIDS patients on antiretroviral therapy: challenges of immunological non-responders","volume":"107","author":"Yang","year":"2020","journal-title":"J Leukoc Biol"},{"key":"10.1016\/j.ebiom.2025.105856_bib10","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.ijid.2019.01.017","article-title":"Incomplete functional T-cell reconstitution in immunological non-responders at one year after initiation of antiretroviral therapy possibly predisposes them to infectious diseases","volume":"81","author":"Shete","year":"2019","journal-title":"Int J Infect Dis"},{"key":"10.1016\/j.ebiom.2025.105856_bib11","doi-asserted-by":"crossref","DOI":"10.1155\/2012\/670957","article-title":"Incomplete immune recovery in HIV infection: mechanisms, relevance for clinical care, and possible solutions","volume":"2012","author":"Gaardbo","year":"2012","journal-title":"Clin Dev Immunol"},{"key":"10.1016\/j.ebiom.2025.105856_bib12","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1146\/annurev-med-042909-093756","article-title":"HIV infection, inflammation, immunosenescence, and aging","volume":"62","author":"Deeks","year":"2011","journal-title":"Annu Rev Med"},{"issue":"7","key":"10.1016\/j.ebiom.2025.105856_bib13","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1097\/QAD.0b013e3282f7cb76","article-title":"CD4+ count and risk of non-AIDS diseases following initial treatment for HIV infection","volume":"22","author":"Baker","year":"2008","journal-title":"AIDS"},{"issue":"4","key":"10.1016\/j.ebiom.2025.105856_bib14","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1086\/655144","article-title":"Low CD4+ T cell count is a risk factor for cardiovascular disease events in the HIV outpatient study","volume":"51","author":"Lichtenstein","year":"2010","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ebiom.2025.105856_bib15","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2022.104072","article-title":"Predictive value of CD8+ T cell and CD4\/CD8 ratio at two years of successful ART in the risk of AIDS and non-AIDS events","volume":"80","author":"Serrano-Villar","year":"2022","journal-title":"EBioMedicine"},{"issue":"6","key":"10.1016\/j.ebiom.2025.105856_bib16","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2020.7954","article-title":"Comparison of overall and comorbidity-free life expectancy between insured adults with and without HIV infection, 2000-2016","volume":"3","author":"Marcus","year":"2020","journal-title":"JAMA Netw Open"},{"key":"10.1016\/j.ebiom.2025.105856_bib17","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2022.103896","article-title":"Ageing with HIV: challenges and biomarkers","volume":"77","author":"Rod\u00e9s","year":"2022","journal-title":"EBioMedicine"},{"issue":"1","key":"10.1016\/j.ebiom.2025.105856_bib18","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1111\/cei.12814","article-title":"Ageing and inflammation in patients with HIV infection","volume":"187","author":"Nasi","year":"2017","journal-title":"Clin Exp Immunol"},{"issue":"4","key":"10.1016\/j.ebiom.2025.105856_bib19","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1016\/j.chom.2020.03.014","article-title":"The biology of the HIV-1 latent reservoir and implications for cure strategies","volume":"27","author":"Cohn","year":"2020","journal-title":"Cell Host Microbe"},{"issue":"7","key":"10.1016\/j.ebiom.2025.105856_bib20","doi-asserted-by":"crossref","first-page":"3704","DOI":"10.1073\/pnas.1917876117","article-title":"Defective HIV-1 proviruses produce viral proteins","volume":"117","author":"Imamichi","year":"2020","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"4","key":"10.1016\/j.ebiom.2025.105856_bib21","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1016\/j.chom.2017.03.008","article-title":"Defective HIV-1 proviruses are expressed and can be recognized by cytotoxic T lymphocytes, which shape the proviral landscape","volume":"21","author":"Pollack","year":"2017","journal-title":"Cell Host Microbe"},{"issue":"10","key":"10.1016\/j.ebiom.2025.105856_bib22","doi-asserted-by":"crossref","first-page":"2470","DOI":"10.1038\/s41564-024-01816-5","article-title":"Silencing the transcriptionally active HIV reservoir to improve treatment outcomes","volume":"9","author":"Prigann","year":"2024","journal-title":"Nat Microbiol"},{"issue":"4","key":"10.1016\/j.ebiom.2025.105856_bib23","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1016\/j.jmb.2011.04.042","article-title":"HIV-1 envelope glycoprotein biosynthesis, trafficking, and incorporation","volume":"410","author":"Checkley","year":"2011","journal-title":"J Mol Biol"},{"issue":"41","key":"10.1016\/j.ebiom.2025.105856_bib24","doi-asserted-by":"crossref","first-page":"23883","DOI":"10.1074\/jbc.270.41.23883","article-title":"The role of human immunodeficiency virus type 1 envelope glycoproteins in virus infection","volume":"270","author":"Freed","year":"1995","journal-title":"J Biol Chem"},{"issue":"4","key":"10.1016\/j.ebiom.2025.105856_bib25","doi-asserted-by":"crossref","first-page":"2119","DOI":"10.1128\/jvi.65.4.2119-2123.1991","article-title":"Human immunodeficiency virus type 1 gp120 envelope glycoprotein regions important for association with the gp41 transmembrane glycoprotein","volume":"65","author":"Helseth","year":"1991","journal-title":"J Virol"},{"issue":"1","key":"10.1016\/j.ebiom.2025.105856_bib26","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/S0042-6822(03)00273-3","article-title":"Role of the gp120 inner domain beta-sandwich in the interaction between the human immunodeficiency virus envelope glycoprotein subunits","volume":"313","author":"Yang","year":"2003","journal-title":"Virology"},{"issue":"5","key":"10.1016\/j.ebiom.2025.105856_bib27","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1016\/j.molcel.2010.02.012","article-title":"Topological layers in the HIV-1 gp120 inner domain regulate gp41 interaction and CD4-triggered conformational transitions","volume":"37","author":"Finzi","year":"2010","journal-title":"Mol Cell"},{"issue":"3","key":"10.1016\/j.ebiom.2025.105856_bib28","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1093\/infdis\/jiad503","article-title":"Plasma human immunodeficiency virus 1 soluble glycoprotein 120 association with correlates of immune dysfunction and inflammation in antiretroviral therapy-treated individuals with undetectable viremia","volume":"229","author":"Benlarbi","year":"2024","journal-title":"J Infect Dis"},{"issue":"3","key":"10.1016\/j.ebiom.2025.105856_bib29","first-page":"251","article-title":"Identification of HIV-1 envelope glycoprotein in the serum of AIDS and ARC patients","volume":"5","author":"Oh","year":"1992","journal-title":"J Acquir Immune Defic Syndr (1988)"},{"issue":"10","key":"10.1016\/j.ebiom.2025.105856_bib30","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1089\/aid.2009.0290","article-title":"Detection of HIV gp120 in plasma during early HIV infection is associated with increased proinflammatory and immunoregulatory cytokines","volume":"26","author":"Rychert","year":"2010","journal-title":"AIDS Res Hum Retroviruses"},{"issue":"7","key":"10.1016\/j.ebiom.2025.105856_bib31","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.1086\/605695","article-title":"HIV-1 envelope protein gp120 is present at high concentrations in secondary lymphoid organs of individuals with chronic HIV-1 infection","volume":"200","author":"Santosuosso","year":"2009","journal-title":"J Infect Dis"},{"issue":"5","key":"10.1016\/j.ebiom.2025.105856_bib32","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1016\/j.chembiol.2023.03.003","article-title":"Temsavir blocks the immunomodulatory activities of HIV-1 soluble gp120","volume":"30","author":"Richard","year":"2023","journal-title":"Cell Chem Biol"},{"issue":"3","key":"10.1016\/j.ebiom.2025.105856_bib33","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0174550","article-title":"HIV-1 gp120 envelope glycoprotein determinants for cytokine burst in human monocytes","volume":"12","author":"Levast","year":"2017","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.ebiom.2025.105856_bib34","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-018-35478-1","article-title":"HIV-1 envelope glycoproteins induce the production of TNF-\u03b1 and IL-10 in human monocytes by activating calcium pathway","volume":"8","author":"Plan\u00e8s","year":"2018","journal-title":"Sci Rep"},{"issue":"5","key":"10.1016\/j.ebiom.2025.105856_bib35","doi-asserted-by":"crossref","first-page":"2633","DOI":"10.1128\/JVI.03230-13","article-title":"Interaction with cellular CD4 exposes HIV-1 envelope epitopes targeted by antibody-dependent cell-mediated cytotoxicity","volume":"88","author":"Veillette","year":"2014","journal-title":"J Virol"},{"issue":"1","key":"10.1016\/j.ebiom.2025.105856_bib36","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1128\/JVI.02868-14","article-title":"The HIV-1 gp120 CD4-bound conformation is preferentially targeted by antibody-dependent cellular cytotoxicity-mediating antibodies in sera from HIV-1-infected individuals","volume":"89","author":"Veillette","year":"2015","journal-title":"J Virol"},{"issue":"3","key":"10.1016\/j.ebiom.2025.105856_bib37","doi-asserted-by":"crossref","first-page":"1863","DOI":"10.1128\/jvi.70.3.1863-1872.1996","article-title":"Antibody cross-competition analysis of the human immunodeficiency virus type 1 gp120 exterior envelope glycoprotein","volume":"70","author":"Moore","year":"1996","journal-title":"J Virol"},{"issue":"12","key":"10.1016\/j.ebiom.2025.105856_bib38","doi-asserted-by":"crossref","first-page":"9722","DOI":"10.1128\/jvi.71.12.9722-9731.1997","article-title":"Analysis of the interaction of the human immunodeficiency virus type 1 gp120 envelope glycoprotein with the gp41 transmembrane glycoprotein","volume":"71","author":"Wyatt","year":"1997","journal-title":"J Virol"},{"issue":"4","key":"10.1016\/j.ebiom.2025.105856_bib39","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/j.tim.2017.10.007","article-title":"Impact of HIV-1 envelope conformation on ADCC responses","volume":"26","author":"Richard","year":"2018","journal-title":"Trends Microbiol"},{"issue":"10","key":"10.1016\/j.ebiom.2025.105856_bib40","doi-asserted-by":"crossref","DOI":"10.1128\/jvi.00960-24","article-title":"Three families of CD4-induced antibodies are associated with the capacity of plasma from people living with HIV to mediate ADCC in the presence of CD4-mimetics","volume":"98","author":"Tauzin","year":"2024","journal-title":"J Virol"},{"issue":"2","key":"10.1016\/j.ebiom.2025.105856_bib41","doi-asserted-by":"crossref","DOI":"10.1128\/mBio.00358-18","article-title":"Uninfected bystander cells impact the measurement of HIV-specific antibody-dependent cellular cytotoxicity responses","volume":"9","author":"Richard","year":"2018","journal-title":"mBio"},{"issue":"6","key":"10.1016\/j.ebiom.2025.105856_bib42","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2022.111624","article-title":"HIV-1 Vpu restricts Fc-mediated effector functions in vivo","volume":"41","author":"Pr\u00e9vost","year":"2022","journal-title":"Cell Rep"},{"key":"10.1016\/j.ebiom.2025.105856_bib43","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/j.ebiom.2015.12.004","article-title":"Small CD4 mimetics prevent HIV-1 uninfected bystander CD4 + T cell killing mediated by antibody-dependent cell-mediated cytotoxicity","volume":"3","author":"Richard","year":"2016","journal-title":"EBioMedicine"},{"issue":"4","key":"10.1016\/j.ebiom.2025.105856_bib44","doi-asserted-by":"crossref","first-page":"2127","DOI":"10.1128\/JVI.02779-15","article-title":"A highly conserved residue of the HIV-1 gp120 inner domain is important for antibody-dependent cellular cytotoxicity responses mediated by anti-cluster A antibodies","volume":"90","author":"Ding","year":"2016","journal-title":"J Virol"},{"issue":"21","key":"10.1016\/j.ebiom.2025.105856_bib45","doi-asserted-by":"crossref","first-page":"11521","DOI":"10.1128\/JVI.01023-12","article-title":"Antibody-dependent cellular cytotoxicity-mediating antibodies from an HIV-1 vaccine efficacy trial target multiple epitopes and preferentially use the VH1 gene family","volume":"86","author":"Bonsignori","year":"2012","journal-title":"J Virol"},{"issue":"1","key":"10.1016\/j.ebiom.2025.105856_bib46","doi-asserted-by":"crossref","first-page":"E69","DOI":"10.1073\/pnas.1217609110","article-title":"Diverse specificity and effector function among human antibodies to HIV-1 envelope glycoprotein epitopes exposed by CD4 binding","volume":"110","author":"Guan","year":"2013","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"14","key":"10.1016\/j.ebiom.2025.105856_bib47","doi-asserted-by":"crossref","first-page":"7029","DOI":"10.1128\/JVI.00171-11","article-title":"An HIV-1 gp120 envelope human monoclonal antibody that recognizes a C1 conformational epitope mediates potent antibody-dependent cellular cytotoxicity (ADCC) activity and defines a common ADCC epitope in human HIV-1 serum","volume":"85","author":"Ferrari","year":"2011","journal-title":"J Virol"},{"issue":"3","key":"10.1016\/j.ebiom.2025.105856_bib48","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1093\/infdis\/jiaa377","article-title":"Clinical trials of broadly neutralizing monoclonal antibodies for human immunodeficiency virus prevention: a review","volume":"223","author":"Mahomed","year":"2021","journal-title":"J Infect Dis"},{"issue":"6","key":"10.1016\/j.ebiom.2025.105856_bib49","doi-asserted-by":"crossref","DOI":"10.3390\/v16060911","article-title":"The use of broadly neutralizing antibodies (bNAbs) in HIV-1 treatment and prevention","volume":"16","author":"Thavarajah","year":"2024","journal-title":"Viruses"},{"issue":"3","key":"10.1016\/j.ebiom.2025.105856_bib50","doi-asserted-by":"crossref","first-page":"1202","DOI":"10.1128\/jvi.65.3.1202-1207.1991","article-title":"Pseudotype formation of murine leukemia virus with the G protein of vesicular stomatitis virus","volume":"65","author":"Emi","year":"1991","journal-title":"J Virol"},{"issue":"7","key":"10.1016\/j.ebiom.2025.105856_bib51","doi-asserted-by":"crossref","DOI":"10.1128\/JVI.02452-16","article-title":"Influence of the envelope gp120 Phe 43 cavity on HIV-1 sensitivity to antibody-dependent cell-mediated cytotoxicity responses","volume":"91","author":"Pr\u00e9vost","year":"2017","journal-title":"J Virol"},{"issue":"24","key":"10.1016\/j.ebiom.2025.105856_bib52","doi-asserted-by":"crossref","DOI":"10.1128\/JVI.01325-19","article-title":"A new family of small-molecule CD4-mimetic compounds contacts highly conserved aspartic acid 368 of HIV-1 gp120 and mediates antibody-dependent cellular cytotoxicity","volume":"93","author":"Ding","year":"2019","journal-title":"J Virol"},{"key":"10.1016\/j.ebiom.2025.105856_bib53","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.jviromet.2015.02.017","article-title":"HIV-1 gp120 dimers decrease the overall affinity of gp120 preparations for CD4-induced ligands","volume":"215\u2013216","author":"Coutu","year":"2015","journal-title":"J Virol Methods"},{"issue":"23","key":"10.1016\/j.ebiom.2025.105856_bib54","doi-asserted-by":"crossref","first-page":"12975","DOI":"10.1128\/JVI.78.23.12975-12986.2004","article-title":"Characterization of the outer domain of the gp120 glycoprotein from human immunodeficiency virus type 1","volume":"78","author":"Yang","year":"2004","journal-title":"J Virol"},{"issue":"5","key":"10.1016\/j.ebiom.2025.105856_bib55","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1016\/j.str.2016.03.005","article-title":"Paring down HIV env: design and crystal structure of a stabilized inner domain of HIV-1 gp120 displaying a major ADCC target of the A32 region","volume":"24","author":"Tolbert","year":"2016","journal-title":"Structure"},{"issue":"5993","key":"10.1016\/j.ebiom.2025.105856_bib56","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1126\/science.1187659","article-title":"Rational design of envelope identifies broadly neutralizing human monoclonal antibodies to HIV-1","volume":"329","author":"Wu","year":"2010","journal-title":"Science"},{"issue":"5187","key":"10.1016\/j.ebiom.2025.105856_bib57","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1126\/science.7973652","article-title":"Efficient neutralization of primary isolates of HIV-1 by a recombinant human monoclonal antibody","volume":"266","author":"Burton","year":"1994","journal-title":"Science"},{"issue":"6049","key":"10.1016\/j.ebiom.2025.105856_bib58","doi-asserted-by":"crossref","first-page":"1633","DOI":"10.1126\/science.1207227","article-title":"Sequence and structural convergence of broad and potent HIV antibodies that mimic CD4 binding","volume":"333","author":"Scheid","year":"2011","journal-title":"Science"},{"issue":"5","key":"10.1016\/j.ebiom.2025.105856_bib59","doi-asserted-by":"crossref","first-page":"1108","DOI":"10.1016\/j.immuni.2016.10.027","article-title":"Identification of a CD4-binding-site antibody to HIV that evolved near-pan neutralization breadth","volume":"45","author":"Huang","year":"2016","journal-title":"Immunity"},{"issue":"5","key":"10.1016\/j.ebiom.2025.105856_bib60","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0125575","article-title":"Identification of CD4-binding site dependent plasma neutralizing antibodies in an HIV-1 infected Indian individual","volume":"10","author":"Khan","year":"2015","journal-title":"PLoS One"},{"issue":"14","key":"10.1016\/j.ebiom.2025.105856_bib61","doi-asserted-by":"crossref","first-page":"7588","DOI":"10.1128\/JVI.00734-12","article-title":"The development of CD4 binding site antibodies during HIV-1 infection","volume":"86","author":"Lynch","year":"2012","journal-title":"J Virol"},{"key":"10.1016\/j.ebiom.2025.105856_bib62","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1146\/annurev-immunol-041015-055515","article-title":"Broadly neutralizing antibodies to HIV and their role in vaccine design","volume":"34","author":"Burton","year":"2016","journal-title":"Annu Rev Immunol"},{"issue":"7446","key":"10.1016\/j.ebiom.2025.105856_bib63","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1038\/nature12053","article-title":"Co-evolution of a broadly neutralizing HIV-1 antibody and founder virus","volume":"496","author":"Liao","year":"2013","journal-title":"Nature"},{"issue":"6","key":"10.1016\/j.ebiom.2025.105856_bib64","doi-asserted-by":"crossref","first-page":"1280","DOI":"10.1016\/j.cell.2015.05.007","article-title":"Structural repertoire of HIV-1-neutralizing antibodies targeting the CD4 supersite in 14 donors","volume":"161","author":"Zhou","year":"2015","journal-title":"Cell"},{"issue":"9","key":"10.1016\/j.ebiom.2025.105856_bib65","article-title":"Incorporating the cluster A and V1V2 targets into a minimal structural unit of the HIV-1 envelope to elicit a cross-clade response with potent Fc-effector functions","volume":"9","author":"Sherburn","year":"2021","journal-title":"Vaccines (Basel)"},{"issue":"1","key":"10.1016\/j.ebiom.2025.105856_bib66","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1186\/s12879-017-2692-2","article-title":"The Canadian HIV and aging cohort study - determinants of increased risk of cardio-vascular diseases in HIV-infected individuals: rationale and study protocol","volume":"17","author":"Durand","year":"2017","journal-title":"BMC Infect Dis"},{"issue":"2","key":"10.1016\/j.ebiom.2025.105856_bib67","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2023-080606","article-title":"Cohort profile: PRESTIGIO, an Italian prospective registry-based cohort of people with HIV-1 resistant to reverse transcriptase, protease and integrase inhibitors","volume":"14","author":"Clemente","year":"2024","journal-title":"BMJ Open"},{"issue":"3","key":"10.1016\/j.ebiom.2025.105856_bib68","doi-asserted-by":"crossref","first-page":"e194","DOI":"10.1016\/S2666-7568(21)00278-6","article-title":"Biological ageing with HIV infection: evaluating the geroscience hypothesis","volume":"3","author":"Montano","year":"2022","journal-title":"Lancet Health Longev"},{"issue":"3","key":"10.1016\/j.ebiom.2025.105856_bib69","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1148\/radiol.2021203297","article-title":"Prevalence and characterization of subclinical coronary atherosclerotic plaque with CT among individuals with HIV: results from the Canadian HIV and aging cohort study","volume":"299","author":"Boldeanu","year":"2021","journal-title":"Radiology"},{"issue":"3","key":"10.1016\/j.ebiom.2025.105856_bib70","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1097\/QAI.0b013e31821d33a5","article-title":"Association between HIV infection, antiretroviral therapy, and risk of acute myocardial infarction: a cohort and nested case-control study using Qu\u00e9bec's public health insurance database","volume":"57","author":"Durand","year":"2011","journal-title":"J Acquir Immune Defic Syndr"},{"issue":"1","key":"10.1016\/j.ebiom.2025.105856_bib71","first-page":"13","article-title":"Kidney disease and HIV infection","volume":"25","author":"Wyatt","year":"2017","journal-title":"Top Antivir Med"},{"issue":"1","key":"10.1016\/j.ebiom.2025.105856_bib72","doi-asserted-by":"crossref","DOI":"10.1136\/bmjgast-2017-000166","article-title":"Mechanisms of liver disease in patients infected with HIV","volume":"4","author":"Kaspar","year":"2017","journal-title":"BMJ Open Gastroenterol"},{"issue":"8","key":"10.1016\/j.ebiom.2025.105856_bib73","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1086\/656412","article-title":"Bone disease in HIV infection: a practical review and recommendations for HIV care providers","volume":"51","author":"McComsey","year":"2010","journal-title":"Clin Infect Dis"},{"issue":"4","key":"10.1016\/j.ebiom.2025.105856_bib74","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1038\/nrneurol.2016.27","article-title":"HIV-associated neurocognitive disorder--pathogenesis and prospects for treatment","volume":"12","author":"Saylor","year":"2016","journal-title":"Nat Rev Neurol"},{"issue":"1","key":"10.1016\/j.ebiom.2025.105856_bib75","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1002\/ijc.23487","article-title":"Cancer risk in people infected with human immunodeficiency virus in the United States","volume":"123","author":"Engels","year":"2008","journal-title":"Int J Cancer"},{"issue":"11","key":"10.1016\/j.ebiom.2025.105856_bib76","doi-asserted-by":"crossref","DOI":"10.1128\/mbio.01827-24","article-title":"CD4 downregulation precedes Env expression and protects HIV-1-infected cells from ADCC mediated by non-neutralizing antibodies","volume":"15","author":"Richard","year":"2024","journal-title":"mBio"},{"issue":"6288","key":"10.1016\/j.ebiom.2025.105856_bib77","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1126\/science.aaf0972","article-title":"HIV-1 therapy with monoclonal antibody 3BNC117 elicits host immune responses against HIV-1","volume":"352","author":"Schoofs","year":"2016","journal-title":"Science"},{"issue":"1","key":"10.1016\/j.ebiom.2025.105856_bib78","doi-asserted-by":"crossref","first-page":"6473","DOI":"10.1038\/s41467-022-34171-2","article-title":"Administration of broadly neutralizing anti-HIV-1 antibodies at ART initiation maintains long-term CD8(+) T cell immunity","volume":"13","author":"Ros\u00e1s-Umbert","year":"2022","journal-title":"Nat Commun"},{"issue":"2","key":"10.1016\/j.ebiom.2025.105856_bib79","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1038\/s41591-019-0747-1","article-title":"Combination anti-HIV-1 antibody therapy is associated with increased virus-specific T cell immunity","volume":"26","author":"Niessl","year":"2020","journal-title":"Nat Med"},{"issue":"11","key":"10.1016\/j.ebiom.2025.105856_bib80","doi-asserted-by":"crossref","first-page":"2424","DOI":"10.1038\/s41591-022-02023-7","article-title":"Early intervention with 3BNC117 and romidepsin at antiretroviral treatment initiation in people with HIV-1: a phase 1b\/2a, randomized trial","volume":"28","author":"Gunst","year":"2022","journal-title":"Nat Med"},{"issue":"4","key":"10.1016\/j.ebiom.2025.105856_bib81","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1097\/COH.0000000000000797","article-title":"Vaccinal effect of HIV-1 antibody therapy: dream or reality?","volume":"18","author":"Naranjo-Gomez","year":"2023","journal-title":"Curr Opin HIV AIDS"},{"issue":"7913","key":"10.1016\/j.ebiom.2025.105856_bib82","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1038\/s41586-022-04597-1","article-title":"Prolonged viral suppression with anti-HIV-1 antibody therapy","volume":"606","author":"Gaebler","year":"2022","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.ebiom.2025.105856_bib83","doi-asserted-by":"crossref","first-page":"7461","DOI":"10.1038\/s41467-024-51848-y","article-title":"Administration of anti-HIV-1 broadly neutralizing monoclonal antibodies with increased affinity to Fc\u03b3 receptors during acute SHIV(AD8-EO) infection","volume":"15","author":"Dias","year":"2024","journal-title":"Nat Commun"},{"issue":"6","key":"10.1016\/j.ebiom.2025.105856_bib84","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1016\/j.cell.2014.08.023","article-title":"Broadly neutralizing anti-HIV-1 antibodies require Fc effector functions for in vivo activity","volume":"158","author":"Bournazos","year":"2014","journal-title":"Cell"},{"issue":"6288","key":"10.1016\/j.ebiom.2025.105856_bib85","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1126\/science.aaf1279","article-title":"Enhanced clearance of HIV-1-infected cells by broadly neutralizing antibodies against HIV-1 in vivo","volume":"352","author":"Lu","year":"2016","journal-title":"Science"},{"issue":"2","key":"10.1016\/j.ebiom.2025.105856_bib86","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/S2055-6640(20)30490-8","article-title":"HIV persistence in the setting of antiretroviral therapy: when, where and how does HIV hide?","volume":"1","author":"Kulpa","year":"2015","journal-title":"J Virus Erad"},{"issue":"2","key":"10.1016\/j.ebiom.2025.105856_bib87","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/j.cell.2021.12.038","article-title":"The loud minority: transcriptionally active HIV-1-infected cells survive, proliferate, and persist","volume":"185","author":"Collora","year":"2022","journal-title":"Cell"},{"issue":"3","key":"10.1016\/j.ebiom.2025.105856_bib88","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1097\/COH.0000000000000849","article-title":"Persistent HIV-1 transcription during ART: time to reassess its significance?","volume":"19","author":"Fombellida-Lopez","year":"2024","journal-title":"Curr Opin HIV AIDS"},{"issue":"31","key":"10.1016\/j.ebiom.2025.105856_bib89","doi-asserted-by":"crossref","first-page":"8783","DOI":"10.1073\/pnas.1609057113","article-title":"Defective HIV-1 proviruses produce novel protein-coding RNA species in HIV-infected patients on combination antiretroviral therapy","volume":"113","author":"Imamichi","year":"2016","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"9","key":"10.1016\/j.ebiom.2025.105856_bib90","doi-asserted-by":"crossref","first-page":"1507","DOI":"10.1016\/j.chom.2023.08.006","article-title":"Spontaneous HIV expression during suppressive ART is associated with the magnitude and function of HIV-specific CD4(+) and CD8(+) T cells","volume":"31","author":"Dub\u00e9","year":"2023","journal-title":"Cell Host Microbe"},{"issue":"9","key":"10.1016\/j.ebiom.2025.105856_bib91","doi-asserted-by":"crossref","first-page":"1494","DOI":"10.1016\/j.chom.2023.08.012","article-title":"An active HIV reservoir during ART is associated with maintenance of HIV-specific CD8(+) T cell magnitude and short-lived differentiation status","volume":"31","author":"Takata","year":"2023","journal-title":"Cell Host Microbe"},{"issue":"6","key":"10.1016\/j.ebiom.2025.105856_bib92","doi-asserted-by":"crossref","DOI":"10.1172\/JCI165245","article-title":"Clonally expanded HIV-1 proviruses with 5'-leader defects can give rise to nonsuppressible residual viremia","volume":"133","author":"White","year":"2023","journal-title":"J Clin Invest"},{"issue":"12","key":"10.1016\/j.ebiom.2025.105856_bib93","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1009982","article-title":"Intragenic proviral elements support transcription of defective HIV-1 proviruses","volume":"17","author":"Kuniholm","year":"2021","journal-title":"PLoS Pathog"},{"issue":"1","key":"10.1016\/j.ebiom.2025.105856_bib94","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1093\/infdis\/jix225","article-title":"HIV antibody level as a marker of HIV persistence and low-level viral replication","volume":"216","author":"Keating","year":"2017","journal-title":"J Infect Dis"},{"key":"10.1016\/j.ebiom.2025.105856_bib95","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.786341","article-title":"Are HIV-1-Specific antibody levels potentially useful laboratory markers to estimate HIV reservoir size? A review","volume":"12","author":"Zaongo","year":"2021","journal-title":"Front Immunol"}],"container-title":["eBioMedicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352396425003007?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352396425003007?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T19:39:08Z","timestamp":1778873948000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2352396425003007"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8]]},"references-count":95,"alternative-id":["S2352396425003007"],"URL":"https:\/\/doi.org\/10.1016\/j.ebiom.2025.105856","relation":{},"ISSN":["2352-3964"],"issn-type":[{"value":"2352-3964","type":"print"}],"subject":[],"published":{"date-parts":[[2025,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"CD4 T cell counts are inversely correlated with anti-gp120 cluster A antibodies in antiretroviral therapy-treated PLWH","name":"articletitle","label":"Article Title"},{"value":"eBioMedicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ebiom.2025.105856","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"105856"}}